MCA Staff Writers

MCA Staff Writers

Presenting Up-to-Date Mesothelioma Topics

Recent Posts

HIPPA and cancer

HIPPA stands for the Health Insurance Portability and Accountability Act and became law in 1996. This law protects your health information that is directly linked to you by your name, address, social security number, insurance identification number, etc. It gave physicians, hospitals, nurses and healthcare practitioners time to comply with the law.

Continue Reading Email Tweet Share
New, promising immunotherapy

Mesothelioma is diagnosed in about 3000 patients in the USA each year. For decades, only academic scientists and clinicians focused on finding effective treatments for mesothelioma. For rare diseases like mesothelioma, the US Food and Drug Administration (FDA) decided to provide incentives to companies that develop products for treatment of rare diseases through a program known as the Orphan Drug Designation program.

Continue Reading Email Tweet Share

Both smoking and asbestos irritate the lungs. Smoking is a well-known trigger for lung cancer. Chronic exposure to smoke (smoking) causes as many as 90% of lung cancers.1

Continue Reading Email Tweet Share
DNA

Doctors use information about each case of mesothelioma to help guide the treatment of each patient. Most commonly, doctors look at how far the mesothelioma has spread which is measured in the tumor-node-metastasis (TNM) stage and the type of tumor cell --epithelioid, biphasic, and sarcomatoid. However, even the same type of mesothelioma—epithelioid— can vary in its rate of growth or aggressiveness. Thus, other factors in mesothelioma must affect its aggressiveness.

Continue Reading Email Tweet Share
DNA

Many chemotherapy regimens can damage nerves that serve most of the body, called peripheral nerves. This damage, technically called chemotherapy-induced peripheral neurotherapy (CIPN), causes pain in about 60% of chemotherapy- treated patients.1 While it often begins after the later cycles, it can linger for years.

Continue Reading Email Tweet Share
Understanding immunotherapy

Tumors, including mesothelioma and the deadly skin cancer melanoma, use several methods to hide from the immune system. Since mesothelioma and melanoma tumors have similar characteristics, some melanoma treatments are being tested for their efficacy on mesothelioma tumors. Many tumors express proteins that turn off the T cells that would normally kill them. Blocking that “off signal” or “checkpoint signal” is a very promising type of immunotherapy for cancer. It’s like opening the handcuffs on a person’s immune response so their immune system can kill the cancer cells.

Continue Reading Email Tweet Share
2 0 1 4Dec19

Is a Clinical Trial Right for Me?

Clinical trial doctor

We often discuss the results of clinical trials so let’s discuss clinical trials in more depth: who participates, what’s being tested, how clinical trials change treatment of future mesothelioma patients.

Continue Reading Email Tweet Share
DNA strand

While a cure for mesothelioma does not exist currently, doctors are working tirelessly to gain a greater understanding of genetic cues that can potentially lead to a cure for mesothelioma. Understanding genetic cues, like genomic mutations, can inform doctors of how mesothelioma develops in patients, which could lead to earlier detection of the disease and creation of individualized treatments for improved prognoses for patients.

Continue Reading Email Tweet Share
Next >

Meet
the Staff

Free Mesothelioma Information Packet

Receive a comprehensive mesothelioma packet free of charge within 24 hours...

Yes   No

Get Started

Featured Authors

Staff Writers

Topics

Archive

Resources

1-800-336-0086

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

YesNo